Sleep Disorder Institute Logo
Inicio Acerca de Nosotros Pacientes Medicos Programa de capacitacion de colegas Contacto

Acerca de Nosotros
Overview
Our Services
Our Team
Our Facilities
Testimonials
In the News
Publicaciones
Webinars
 
 

2004

Zammit, G. K., McNabb, L. J. , Caron, J., Amato, D. A., & Roth , T. (2004). Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Current Medical Research and Opinion, 1979 – 1991.

Sackner-Bernstein JD, Godin S. Increasing Organ Transplantation – Fairly. Transplantation, 15 de enero de 2004 15;77(1):157-9.

Behr TM, Willette RN, Coatney RW, Berova M, Angermann CE, Anderson K, Sackner- Bernstein JD and Barone FC. Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial MCP-1 and inflammation in hypertensive heart disease. Journal of Hypertension, 2004;22(3):583-92.

Sackner-Bernstein JD, Hart D. Is There an Optimal Strategy for Neurohormonal Antagonism? Mount Sinai Journal of Medicine, marzo de 2004;71(2):115-26.

Sackner-Bernstein JD, Farmer DM. Biventricular Pacing as an Alternative to Transplant. Coronary Artery Disease, 2004;15(2):81-5.

Sackner-Bernstein JD. Practical guidelines to optimize effectiveness of beta-blockade in patients postinfarction and in those with chronic heart failure. Am J Cardiol. 6 de mayo de 2004;93(9A):69B-73B.

 


Archivos


2007

2006

2005

2004

2003


2002

2001

2000


 

 

_____________________________________________________________________

 

Contacto | Política de privacidad y condiciones de uso | Mapa del sitio | Clinilabs
423 West 55th Street, 4th Floor New York, NY 10019 • tel: 212.994.5100 • fax: 212.994.5101 • correo electrónico:info@sleepny.com
© The Sleep Disorders Institute 2008